Monash IVF Group Limited announced the Managing Director and CEO, Mr. James Thiedeman has tendered his resignation to take up a leadership role in a non-competing unlisted health care organisation outside the women's health sector with international growth plans. The Board of Monash IVF Group Limited and Mr. Thiedeman have agreed he will work through his six month notice period and remain with the Company for the release of the company's full year financial results for 2017. During this time, Mr. Thiedeman will support the business and work with the Board to ensure a smooth transition to the new Managing Director and CEO.